Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonergic gene variation in substance use pharmacotherapy: a systematic review.

Pharmacogenomics - 1 Jan 2015

Bauer Isabelle E, Graham David P, Soares Jair C, Nielsen David A

Abstract excerpt

Drug addiction is a serious disease with damaging effects on the brain and physical health. Despite the increase in the number of affected individuals, there are few effective pharmacological treatment options for substance use disorders. The study of the influence of an individual's genetic features on the treatment response may help to identify more efficacious treatment options. This systematic review focuses...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to TPH2 gene
Share to Genetic Variation
Share to Serotonin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Serotonin Plasma Membrane Transport Proteins

Share to Substance-Related Disorders

Share to Tryptophan Hydroxylase

Source

Open in PubMed Open full text

Identifiers

PMID: 26265436
DOI: 10.2217/pgs.15.72
PMCID: PMC4573253

Genes

TPH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonergic gene variation in substance use pharmacotherapy: a systematic review.PMID 26265436Read ↗

Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

Effect of serotonin receptor gene variants on substance use disorders.Semantic proximity Read ↗

[Pharmacogenetics and the treatment of addiction].Semantic proximity Read ↗

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Semantic proximity Read ↗

Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Semantic proximity Read ↗

Pharmacogenetics of addiction therapy.Semantic proximity Read ↗

TPH2 polymorphisms across the spectrum of psychiatric morbidity: A systematic review and meta-analysis.Semantic proximity Read ↗

Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study.Semantic proximity Read ↗

TPH1 and 5-HTTLPR Genes Specifically Interact in Opiate Dependence but Not in Alcohol Dependence.Semantic proximity Read ↗

Exploring the Roles of 5-HTTLPR, STin2, 5-HT2A, and TPH2 Variants in Heroin DependenceSemantic proximity Read ↗

Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.